For the Quarter Ending March 2026
Zidovudine Prices in North America
- In United States, the Zidovudine Price Index rose quarter over quarter in Q1 2026, driven by elevated production costs.
- The Zidovudine Production Cost Trend increased in March 2026 as producer prices rose 4.0 percent.
- Consumer prices increased 3.3 percent in March 2026, raising transportation costs for the Zidovudine Price Index.
- Industrial production grew 0.7 percent in March 2026, tightening utility availability for energy-intensive Zidovudine synthesis.
- The Zidovudine Demand Outlook stabilized as retail sales grew 4.0 percent in March 2026, supporting pharmacies.
- Unemployment at 4.3 percent and consumer confidence at 91.8 in March 2026 maintained Zidovudine prescription renewals.
- The Manufacturing Index expanded in March 2026, ensuring stable supply chains for Zidovudine formulation and packaging.
- The Zidovudine Price Forecast remained elevated as demand weakened in developed nations during February 2026.
- Federal initiatives proposed in January 2026 strengthened domestic pharmaceutical supply chains for essential Zidovudine availability.
Why did the price of Zidovudine change in March 2026 in North America?
- Thymidine feedstock bottlenecks inflated Zidovudine production cost structures significantly during February 2026 in North America.
- Colder weather drove up natural gas consumption for space heating during January and February 2026.
- Surging liquefied natural gas exports tightened domestic energy balances for pharmaceutical manufacturing in March 2026.
Zidovudine Prices in Europe
- In Germany, the Zidovudine Price Index rose quarter-over-quarter in Q1 2026, driven by surging energy and feedstock costs.
- In March 2026, consumer inflation reached 2.7 percent and producer prices fell to -0.2 percent, impacting Zidovudine costs.
- Industrial production stagnated at 0.0 percent and retail sales grew 0.7 percent in February 2026, sustaining Zidovudine demand.
- Unemployment held at 4.2 percent in February 2026, though consumer confidence dropped to -24.7 in March 2026, affecting Zidovudine.
- The Manufacturing Index expanded in March 2026, supporting a robust Zidovudine Demand Outlook for essential HIV antiretroviral therapies.
- Ammonia feedstock and wholesale electricity costs spiked in Q1 2026, significantly elevating the regional Zidovudine Production Cost Trend.
- Inbound shipments of nitrogen-based precursors faced severe disruptions in Q1 2026, tightening regional chemical inventories for pharmaceutical manufacturers.
- The Zidovudine Price Forecast indicated sustained upward pressure in Q1 2026 as the regional Zidovudine Price Index climbed.
Why did the price of Zidovudine change in March 2026 in Europe?
- European natural gas prices surged in January 2026 due to rapid reserve depletion and geopolitical risks.
- Ammonia feedstock costs remained elevated in Q1 2026 due to severe Middle East supply disruptions.
- Imports of cheaper Asian chemical products weakened in Q1 2026 amid regional transit chokepoint bottlenecks.
Zidovudine Prices in APAC
- In China, the Zidovudine Price Index rose quarter-over-quarter in Q1 2026, driven by surging upstream petrochemical production costs.
- The Zidovudine Production Cost Trend escalated in March 2026 as the Producer Price Index increased by 0.5%.
- Consumer prices rose 1.0% while retail sales grew 1.7% in March 2026, supporting stable inelastic procurement demand.
- Industrial production grew 5.7% and the Manufacturing Index expanded in March 2026, ensuring strong Zidovudine supply availability.
- Unemployment reached 5.4% in March 2026 and consumer confidence hit 91.6 in February 2026, straining healthcare budgets.
- The Zidovudine Demand Outlook strengthened in Q1 2026, supported by robust active pharmaceutical ingredient outsourcing and acquisitions.
- Supply chain inventories tightened in Q1 2026 as Chinese export flows faced strategic uncertainty from rising protectionist measures.
- The Zidovudine Price Forecast indicated upward pressure during Q1 2026 as major chemical suppliers implemented steep price hikes.
Why did the price of Zidovudine change in March 2026 in APAC?
- Brent crude prices spiked in March 2026, causing severe cost inflation across pharmaceutical chemical feedstocks.
- Production costs for essential petrochemical solvents used in Zidovudine synthesis surged significantly during March 2026.
- Active pharmaceutical ingredient supply chains tightened in Q1 2026 amid global restructuring and geopolitical disruptions.
For the Quarter Ending December 2025
Zidovudine Prices in North America
- In United States, the Zidovudine Price Index rose in Q4 2025, driven by increasing production costs.
- Zidovudine production costs increased in Q4 2025, influenced by a 3.0% PPI rise in November 2025.
- Rising CPI by 2.7% in December 2025 contributed to higher raw material and labor expenses.
- U.S. natural gas futures posted gains in Q4 2025, adding to overall energy feedstock costs.
- Demand for Zidovudine remained stable in Q4 2025, driven by consistent healthcare needs.
- The Zidovudine Price Index faced upward pressure in Q4 2025, influenced by rising input costs.
- Trade flow data for Zidovudine in Q4 2025 was limited due to a federal government shutdown.
- Industrial production expanded by 2.0% in December 2025, supporting a stable manufacturing environment.
- A 4.4% unemployment rate in December 2025 indicated a strong labor market, impacting labor costs.
Why did the price of Zidovudine change in December 2025 in North America?
- Rising input costs, evidenced by a 3.0% PPI increase in November 2025, pressured prices.
- Higher labor costs due to a 4.4% unemployment rate in December 2025 increased production expenses.
- Increased CPI by 2.7% in December 2025 impacted raw material and operational costs.
Zidovudine Prices in APAC
- In China, the Zidovudine Price Index remained stable quarter-over-quarter in Q4 2025, supported by robust industrial production.
- Zidovudine production costs declined in December 2025, influenced by a negative Producer Price Index of -1.9% year-over-year.
- Demand for Zidovudine was prioritized in 2025, driven by increased government expenditure on health in November 2025.
- The Manufacturing Index expanded in December 2025, indicating a healthy industrial environment for Zidovudine supply chains.
- China's medicine exports, including chemical active pharmaceutical ingredients, steadily increased during the first eleven months of 2025.
- Overall economic growth moderated in Q4 2025, with retail sales growing 0.9% year-over-year in December 2025.
- Zidovudine's supply capacity was supported by 5.2% year-over-year industrial production growth in December 2025.
- The stable unemployment rate of 5.1% in December 2025 indirectly supported consistent healthcare funding for Zidovudine.
Why did the price of Zidovudine change in December 2025 in APAC?
- Zidovudine production costs declined in December 2025, influenced by a -1.9% Producer Price Index year-over-year.
- Government expenditure on health strengthened in November 2025, supporting stable demand for Zidovudine.
- Industrial production grew by 5.2% year-over-year in December 2025, ensuring a robust supply chain.
Zidovudine Prices in Europe
- In Germany, the Zidovudine Price Index remained stable in Q4 2025, influenced by mixed market signals.
- Zidovudine production costs declined in December 2025, as the Producer Price Index decreased 2.5% year-over-year.
- Operational costs for Zidovudine manufacturers increased in December 2025, with the Consumer Price Index rising 1.8% year-over-year.
- Demand for Zidovudine was supported by a 1.1% rise in retail sales in November 2025, bolstering healthcare funding.
- The Manufacturing Index contracted in December 2025, indicating a broader economic slowdown impacting Zidovudine demand.
- N,N-dimethylformamide (DMF) prices were firm in Europe during December 2025, impacting Zidovudine production expenses.
- Industrial production expanded 0.8% in October 2025, ensuring stable supply chain reliability for Zidovudine.
- Consumer confidence declined to -17.5 in December 2025, indirectly pressuring public healthcare budgets for Zidovudine.
Why did the price of Zidovudine change in December 2025 in Europe?
- Producer Price Index declined 2.5% year-over-year in December 2025, reducing Zidovudine manufacturing input costs.
- N,N-dimethylformamide (DMF) prices remained firm in Europe in December 2025, maintaining some cost pressure.
- The Manufacturing Index contracted in December 2025, signaling broader economic slowdown impacting demand.
For the Quarter Ending September 2025
Zidovudine Prices in North America
- In United States, the Zidovudine Price Index rose quarter-over-quarter in Q3 2025, driven by escalating production costs.
- Zidovudine production costs increased due to a 2.6% year-over-year rise in PPI in August 2025.
- National health spending accelerated in 2025, outpacing GDP, supporting Zidovudine demand outlook.
- U.S. natural gas and retail electricity prices increased year-over-year in September 2025, raising manufacturing expenses.
- A 3.0% year-over-year CPI in September 2025 indicated moderate consumer inflation, affecting Zidovudine operational costs.
- U.S. pharmaceutical exports increased July-August 2025, while imports decreased, impacting Zidovudine trade flows.
- Industrial production showed near stagnation at 0.1% year-over-year in September 2025, affecting Zidovudine supply efficiency.
- Strong retail sales, up 5.42% year-over-year in September 2025, indirectly supported the healthcare ecosystem for Zidovudine.
- The Zidovudine Price Forecast points to continued upward pressure due to persistent input cost inflation and robust health spending.
Why did the price of Zidovudine change in September 2025 in North America?
- Producer Price Index rose 2.6% year-over-year in August 2025, increasing Zidovudine raw material costs.
- U.S. natural gas and retail electricity prices increased in September 2025, elevating Zidovudine production expenses.
- National health spending accelerated in 2025, supporting Zidovudine demand despite weak industrial production.
Zidovudine Prices in APAC
- Zidovudine Price Index fell in China, Q3 2025, due to declining costs and global overcapacity.
- Production costs for Zidovudine decreased in September 2025, due to a 2.3% PPI decline.
- Zidovudine demand outlook strong, fueled by aging population and rising healthcare expenditure.
- China's Industrial Production increased 6.5% in September 2025, supporting a stable economy.
- Retail sales grew 3.0% in September 2025, contributing to overall economic stability.
- Consumer Price Index declined 0.3% in September 2025, reflecting deflationary pressures.
- Manufacturing Index was Contracting in September 2025, signaling overall industrial activity slowdown.
- Consumer confidence index was 89.6 in September 2025, reflecting caution among consumers.
- China's pharmaceutical and API exports grew strongly in Q3 2025, showing robust demand.
- Unemployment rate was 5.2% in September 2025, indicating a stable labor market.
Why did the price of Zidovudine change in September 2025 in APAC?
- Producer Price Index declined 2.3% in September 2025, reducing Zidovudine production costs.
- Global overcapacity in chemical building blocks persisted in Q3 2025, exerting downward price pressure.
- Consumer Price Index declined 0.3% in September 2025, contributing to a deflationary market.
Zidovudine Prices in Europe
- In Germany, the Zidovudine Price Index fell quarter-over-quarter in Q3 2025, influenced by softening producer prices for the chemical industry.
- Zidovudine production costs faced upward pressure from a 2.4% CPI increase in September 2025, despite a -1.7% PPI decrease.
- Demand for Zidovudine strengthened in Q3 2025, driven by Germany's expanding pharmaceutical market and healthcare needs.
- The Manufacturing Index showed contracting industrial activity in September 2025, alongside a -1.0% industrial production decline.
- Overall chemical production in Germany declined in Q3 2025, with subdued capacity utilization, affecting Zidovudine supply.
- German pharmaceutical product imports increased markedly in Q3 2025, influencing domestic Zidovudine market dynamics.
- Elevated energy and raw material costs persisted in Q3 2025, despite stable European natural gas prices.
- A low 3.9% unemployment rate in September 2025 supported healthcare funding, positively impacting Zidovudine demand.
Why did the price of Zidovudine change in September 2025 in Europe?
- Softening producer prices for the German chemical industry in Q3 2025 reduced cost pressures.
- Increased German imports of pharmaceutical products in Q3 2025 intensified market competition.
- Elevated energy and raw material costs in Q3 2025 exerted upward pressure on Zidovudine production.
